Scott M Dehm

33PUBLICATIONS
283CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Jun 17, 2026
3D genome architecture and epigenetic regulation of lineage identity in advanced prostate cancer.

|Mar 20, 2026
Tumor-specific lncRNA IGF1R-AS1 trans-regulates chromatin interactions associated with oncogenic MYC signaling.

Yongyong Yang, Ting-You Wang, Joshua Fry

|Jan 26, 2026
Evolution of AR and Non-AR Alterations in ctDNA of Patients with Metastatic Prostate Cancer Treated in the Phase III Alliance A031201 Trial.

José C Valentín López, Chenxi Yu, Todd P Knutson

|Jul 25, 2025
Off-pore Nucleoporin sPOM121 Transcriptionally Propels β-Catenin-driven Tumor Progression and Immune Escape in Prostate Cancer.

Perumalraja Kirthika, Vijayakumar Jawalagatti, Peiyao Li

|May 13, 2025
CHD1 status drives divergent metabolic pathways in SPOP-mutant prostate cancer.

Jacob J Orme, Emmanuel S Antonarakis, Scott M Dehm

|Apr 01, 2025
High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes.

Marina N Sharifi, Jamie M Sperger, Amy K Taylor

Pageof 6

Frequent Collaborators

6 joint publications

Emmanuel S Antonarakis

5 joint publications

Himisha Beltran

5 joint publications

Samuel P Pitzen

5 joint publications

Elisabeth I Heath